Citation: | QI Likai, DI Bin. Advances in research on pharmaceutical impurities[J]. Journal of China Pharmaceutical University, 2015, 46(3): 257-263. DOI: 10.11665/j.issn.1000-5048.20150301 |
[1] |
Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia:Part 2(中华人民共和国药典:二部)[S].Beijing:China Medical Science Press,2010:310-312.
|
[2] |
European Medicines Agency(EMA).Guideline on the limits of genotoxic impurities[EB/OL].[2015-03-02] .http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002903.pdf.
|
[3] |
U.S.Department of Health and Human Services Food and Drug Administration(FDA).Guidance for Industry:Genotoxic and Carcinogenic Impurities in Drug Substances and Products:Recommended Approaches[EB/OL].(2008-12-03)[2015-03-02] .http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079235.pdf.
|
[4] |
Van Wijk AM,Niederländer HAG,Siebum AHG,et al.A new derivatization reagent for LC-MS/MS screening of potential genotoxic alkylation compounds[J].J Pharm Biomed Anal,2013,74:133-140.
|
[5] |
Wu LM,Liu DQ,Vogt FG,et al.Gas-phase derivatization via the Meerwein reaction for selective and sensitive LC-MS analysis of epoxides in active pharmaceutical ingredients[J].J Pharm Biomed Anal,2011,56(5):1106-1111.
|
[6] |
Ueyama E,Tamura K,Mizukawa K,et al.Realistic prediction of solid pharmaceutical oxidation products by using a novel forced oxidation system[J].J Pharm Sci,2014,103(4):1184-1193.
|
[7] |
Grushka E,Grinberg N.Advances in chromatography.Vol.50[M].Boca Raton:CRC,2012:139-235.
|
[8] |
Yamamoto E,Niijima J,Asakawa N.Selective determination of potential impurities in an active pharmaceutical ingredient using HPLC-SPE-HPLC[J].J Pharm Biomed Anal,2013,84:41-47.
|
[9] |
Berta R,Babják M,Gazdag M.A study of some practical aspects of high temperature liquid chromatography in pharmaceutical applications[J].J Pharm Biomed Anal,2011,54(3):458-462.
|
[10] |
Gallinella B,Bucciarelli L,Zanitti L,et al.Direct separation of the enantiomers of oxaliplatin on a cellulose-based chiral stationary phase in hydrophilic interaction liquid chromatography mode[J].J Chromatogr A,2014,1339:210-213.
|
[11] |
Dong MW,Zhang K.Ultra-high-pressure liquid chromatography(UHPLC)in method development[J].Trends Anal Chem,2014,63:21-30.
|
[12] |
Reyes-Reyes ML, Roa-Morales G, Melgar-Fernández R, et al. UHPLC determination of enantiomeric purity of sertraline in the presence of its production impurities[J].Chromatographia,2014,77(19/20):1315-1321.
|
[13] |
Fekete S,Kohler I,Rudaz S,et al.Importance of instrumentation for fast liquid chromatography in pharmaceutical analysis[J].J Pharm Biomed Anal,2014,87:105-119.
|
[14] |
Marley A,Connolly D.Determination of(R)-timolol in(S)-timolol maleate active pharmaceutical ingredient:Validation of a new supercritical fluid chromatography method with an established normal phase liquid chromatography method[J].J Chromatogr A,2014,1325:213-220.
|
[15] |
Brondz I,Ekeberg D,Bell DS,et al.Nature of the main contaminant in the drug primaquine diphosphate:SFC and SFC-MS methods of analysis[J].J Pharm Biomed Anal,2007,43(3):937-944.
|
[16] |
Ramisetti,NR,Kuntamukkala R,Lakshetti S,et al.Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS:development and validation of a stability indicating RP-HPLC method[J].J Pharm Biomed Anal,2014,95:256-264.
|
[17] |
Rinaldi F,Fan J,Pathirana C,et al.Semi-preparative LC-SPE-cryoflow NMR for impurity identifications:use of mother liquor as a better source of impurities[J].Magn Reson Chem,2013,51(9):517-522.
|
[18] |
Zhang Y,Zeng L,Pham C,et al.Preparative two-dimensional liquid chromatography/mass spectrometry for the purification of complex pharmaceutical samples[J].J Chromatogr A,2014,1324:86-95.
|
[19] |
Zeng L,Xu R,Zhang Y,et al.Two-dimensional supercritical fluid chromatography/mass spectrometry for the enantiomeric analysis and purification of pharmaceutical samples[J].J Chromatogr A,2014,1218(20):3080-3088.
|
[20] |
Li S,Wang W,Tang H,et al.Comparison of counter-current chromatography and preparative high performance liquid chromatography applied to separating minor impurities in drug preparations[J].J Chromatogr A,2014,1344:51-58.
|
[21] |
Xie XX,Sun BL,Yang YF.Study on removing(-)-bicuculline from Corydalis Decumbentis Rhizomatotal alkaloids by fast centrifugal partition chromatography[J].Chin Tradit Herbal Drugs(中草药),2014,45(19):2787-2792.
|
[22] |
Amarouche N,Boudesocque L,Sayagh C,et al.Purification of a modified cyclosporine A by co-current centrifugal partition chromatography:process development and intensification[J].J Chromatogr A,2013,1311:72-78.
|
[23] |
Raman NV,Prasad AV,Reddy KR.Sensitive derivatization methods for the determination of genotoxic impurities in drug substances using hyphenated techniques[J].J Pharm Biomed Anal,2014,89:276-281.
|
[24] |
Fu M,Lu Q,Hewitt E,et al.Ultra high performance liquid chromatography coupled with high resolution quantitation mass spectrometry method development and validation for determining genotoxic 2,5-dichlorobenzoyl chloride in MLN9708 drug substance[J].J Pharm Biomed Anal,2014,89:233-239.
|
[25] |
Neu V,Bielow C,Gostomski I,et al.Rapid and comprehensive impurity profiling of synthetic thyroxine by ultrahigh-performance liquid chromatography-high-resolution mass spectrometry[J].Anal Chem,2013,85(6):3309-3317.
|
[26] |
Kind T, Fiehn O. Seven golden rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry[J].BMC Bioinf,2007,8(1):105.
|
[27] |
Foti C,Alsante K,Cheng G,et al.Tools and workflow for structure elucidation of drug degradation products[J].Trends Anal Chem,2013,49:89-99.
|
[28] |
Awasthi A,Razzak M,Al-Kassas R,et al.Separation and identification of degradation products in eprinomectin formulation using LC,LTQ FT-MS,H/D exchange,and NMR[J].J Pharm Biomed Anal,2012,63:62-73.
|
[29] |
Smith M,Thickitt C.The benefit of sample pretreatment and use of MS10 on the Orbitrap for the analysis of pentasaccharides[J].Rapid Commun Mass Spectrom,2009,23(18):3018-3022.
|
[30] |
Shah RP,Sahu A,Singh S.Identification and characterization of degradation products of irbesartan using LC-MS/TOF,MSn,on-line H/D exchange and LC-NMR[J].J Pharm Biomed Anal,2010,51(5):1037-1046.
|
[31] |
Chen GD,Khusid A,Daaro I,et al.Structural identification of trace level enol tautomer impurity by on-line hydrogen/deuterium exchange HR-LC/MS in a LTQ-Orbitrap hybrid mass spectrometer[J].J Mass Spectrom,2007,42(7):967-970.
|
[32] |
Shah RP, Garg A, Putlur SP, et al. Practical and economical implementation of online H/D exchange in LC-MS[J].Anal Chem,2013,85(22):10904-10912.
|
[33] |
Jiang MH,Yu XB,Mao LS,et al.Quantitative determination of 10-O-(N,N-dimethylaminoethyl)-ginkgolide B methanesulfonate by nuclear magnetic resonance[J].J China Pharm Univ(中国药科大学学报),2013,44(4):339-342.
|
[34] |
Foley DA,Wang J,Maranzano B,et al.Online NMR and HPLC as a reaction monitoring platform for pharmaceutical process development[J].Anal Chem,2013,85(19):8928-8932.
|
[35] |
Kovacs H,Moskau D,Spraul M.Cryogenically cooled probes—a leap in NMR technology[J].Prog Nucl Magn Reson Spectrosc,2005,46(2):131-155.
|
[36] |
Devenport NA,Sealey LC,Alruways FH,et al.Direct detection of a sulfonate ester genotoxic impurity by atmospheric-pressure thermal desorption-extractive electrospray-mass spectrometry[J].Anal Chem,2013,85(13):6224-6227.
|
[37] |
Neu V,Bielow C,Reinert K,et al.Ultrahigh-performance liquid chromatography-ultraviolet absorbance detection-high-resolution-mass spectrometry combined with automated data processing for studying the kinetics of oxidative thermal degradation of thyroxine in the solid state[J].J Chromatogr A,2014,1371:196-203.
|
[38] |
McGovern T,Jacobson-Kram D.Regulation of genotoxic and carcinogenic impurities in drug substances and products[J].Trends Anal Chem,2006,25(8):790-795.
|
[39] |
Raman NVVSS,Prasad AVSS,Reddy KR.Strategies for the identification,control and determination of genotoxic impurities in drug substances:a pharmaceutical industry perspective[J].J Pharm Biomed Anal,2011,55(4):662-667.
|
[40] |
Kakasaheb NA,Ramakrishna K,Srinivasarao V.Method development and validation by GC-MS for quantification of 1-chloroethyl cyclohexyl carbonate as a genotoxic impurity in candesartan cilexetil drug substance[J].Int J Pharm Pharm Sci,2014,6(11):370-372.
|
[41] |
Cassano A,Raitano G,Mombelli E,et al.Evaluation of QSAR models for the prediction of Ames genotoxicity:a retrospective exercise on the chemical substances registered under the EU REACH regulation[J].J Environ Sci Health Part C,2014,32(3):273-298.
|
[42] |
European Medicines Agency(EMA).Questions and answers on the ‘Guideline on the limits of genotoxic impurities’[EB/OL].(2010-09-23)[2015-03-02] .http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002907.pdf.
|
[1] | HUANG Yu, ZHANG Yinsheng. Advances in the synthetic methods of bicyclo[1.1.1]pentane derivatives[J]. Journal of China Pharmaceutical University, 2022, 53(2): 137-145. DOI: 10.11665/j.issn.1000-5048.20220202 |
[2] | YANG Ruocong, DUAN Feipeng, CHAO Jiahong, TIAN Pengpeng, YAN Zhiyong, LI Shaojing. Advances of microRNA activity in innate immunity[J]. Journal of China Pharmaceutical University, 2017, 48(4): 396-406. DOI: 10.11665/j.issn.1000-5048.20170403 |
[3] | XIN Minhang, ZHANG Sanqi. Advances in PI3Kδ selective inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 503-510. DOI: 10.11665/j.issn.1000-5048.20160501 |
[4] | JIANG Lu, CHEN Dandan, SUN Minjie, PING Qineng, ZHANG Can. Advances of wax matrix tablets[J]. Journal of China Pharmaceutical University, 2016, 47(4): 497-502. DOI: 10.11665/j.issn.1000-5048.20160418 |
[5] | YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417 |
[6] | RUAN Xiaoling, ZHENG Xiangyuan, XU Jie, DING Li, ZHENG Feng. Advances in analytical techniques for the determination of genotoxic impurities in pharmaceuticals[J]. Journal of China Pharmaceutical University, 2016, 47(3): 267-274. DOI: 10.11665/j.issn.1000-5048.20160303 |
[7] | WANG Xue, ZHANG Can, PING Qineng. Advances of 3D printing technology in advanced pharmaceutical preparations[J]. Journal of China Pharmaceutical University, 2016, 47(2): 140-147. DOI: 10.11665/j.issn.1000-5048.20160203 |
[8] | CHEN Qingyu, ZHOU Jianping, HUO Meirong. Advances in the nanotechnology-based drug delivery systems of silymarin[J]. Journal of China Pharmaceutical University, 2015, 46(3): 376-384. DOI: 10.11665/j.issn.1000-5048.20150320 |
[9] | SUN Zhan-yi, CAI Hui, HUANG Zhi-hua, SHI Lei, CHEN Yong-xiang, LI Yan-mei. Advances of glycopeptide-associated tumor vaccines[J]. Journal of China Pharmaceutical University, 2012, 43(2): 97-106. |
[10] | XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106. |